Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Filings indexed 2,570 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings
2026-05-19 English
ARS - ILLUMINA, INC. (0001110803) (Filer)
Annual Report
2026-04-09 English
DEF 14A - ILLUMINA, INC. (0001110803) (Filer)
Proxy Solicitation & Information Statement
2026-04-09 English
8-K - ILLUMINA, INC. (0001110803) (Filer)
Regulatory Filings
2026-04-02 English
SCHEDULE 13G/A - ILLUMINA, INC. (0001110803) (Subject)
Major Shareholding Notification
2026-03-27 English
4 - ILLUMINA, INC. (0001110803) (Filer)
Director's Dealing
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.